343 related articles for article (PubMed ID: 30784671)
21. Characterization of the Changes in Cardiac Structure and Function in Mice Treated With Anthracyclines Using Serial Cardiac Magnetic Resonance Imaging.
Farhad H; Staziaki PV; Addison D; Coelho-Filho OR; Shah RV; Mitchell RN; Szilveszter B; Abbasi SA; Kwong RY; Scherrer-Crosbie M; Hoffmann U; Jerosch-Herold M; Neilan TG
Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27923796
[TBL] [Abstract][Full Text] [Related]
22. Rac1-mediated cardiac damage causes diastolic dysfunction in a mouse model of subacute doxorubicin-induced cardiotoxicity.
Ohlig J; Henninger C; Zander S; Merx M; Kelm M; Fritz G
Arch Toxicol; 2018 Jan; 92(1):441-453. PubMed ID: 28710503
[TBL] [Abstract][Full Text] [Related]
23. Cardiac Magnetic Resonance and Cardio-Oncology: Does T
Yu AF; Chan AT; Steingart RM
J Am Coll Cardiol; 2019 Feb; 73(7):792-794. PubMed ID: 30784672
[No Abstract] [Full Text] [Related]
24. An integrated characterization of serological, pathological, and functional events in doxorubicin-induced cardiotoxicity.
Cove-Smith L; Woodhouse N; Hargreaves A; Kirk J; Smith S; Price SA; Galvin M; Betts CJ; Brocklehurst S; Backen A; Radford J; Linton K; Roberts RA; Schmitt M; Dive C; Tugwood JD; Hockings PD; Mellor HR
Toxicol Sci; 2014 Jul; 140(1):3-15. PubMed ID: 24675088
[TBL] [Abstract][Full Text] [Related]
25. Toll-like receptor 4 (TLR4) expression is correlated with T2* iron deposition in response to doxorubicin treatment: cardiotoxicity risk assessment.
Trofenciuc NM; Bordejevic AD; Tomescu MC; Petrescu L; Crisan S; Geavlete O; Mischie A; Onel AFM; Sasu A; Pop-Moldovan AL
Sci Rep; 2020 Oct; 10(1):17013. PubMed ID: 33046755
[TBL] [Abstract][Full Text] [Related]
26. Quantification of doxorubicin-induced interstitial myocardial fibrosis in a beagle model using equilibrium contrast-enhanced computed tomography: A comparative study with cardiac magnetic resonance T1-mapping.
Zhou Z; Xu L; Wang R; Varga-Szemes A; Durden JA; Joseph Schoepf U; Sun Z; Fan Z
Int J Cardiol; 2019 Apr; 281():150-155. PubMed ID: 30738608
[TBL] [Abstract][Full Text] [Related]
27. CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging.
Radunski UK; Lund GK; Stehning C; Schnackenburg B; Bohnen S; Adam G; Blankenberg S; Muellerleile K
JACC Cardiovasc Imaging; 2014 Jul; 7(7):667-75. PubMed ID: 24954462
[TBL] [Abstract][Full Text] [Related]
28. Cardiac magnetic resonance including parametric mapping in acute Takotsubo syndrome: Preliminary findings.
Dabir D; Luetkens J; Kuetting DLR; Feisst A; Isaak A; Schild HH; Thomas D
Eur J Radiol; 2019 Apr; 113():217-224. PubMed ID: 30927950
[TBL] [Abstract][Full Text] [Related]
29. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy.
Cardinale D; Colombo A; Bacchiani G; Tedeschi I; Meroni CA; Veglia F; Civelli M; Lamantia G; Colombo N; Curigliano G; Fiorentini C; Cipolla CM
Circulation; 2015 Jun; 131(22):1981-8. PubMed ID: 25948538
[TBL] [Abstract][Full Text] [Related]
30. Decreased Soluble Guanylate Cyclase Contributes to Cardiac Dysfunction Induced by Chronic Doxorubicin Treatment in Mice.
Vandenwijngaert S; Swinnen M; Walravens AS; Beerens M; Gillijns H; Caluwé E; Tainsh RE; Nathan DI; Allen K; Brouckaert P; Bartunek J; Scherrer-Crosbie M; Bloch KD; Bloch DB; Janssens SP; Buys ES
Antioxid Redox Signal; 2017 Feb; 26(4):153-164. PubMed ID: 27505125
[TBL] [Abstract][Full Text] [Related]
31. Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer.
Arciniegas Calle MC; Sandhu NP; Xia H; Cha SS; Pellikka PA; Ye Z; Herrmann J; Villarraga HR
BMC Cancer; 2018 Oct; 18(1):1037. PubMed ID: 30359235
[TBL] [Abstract][Full Text] [Related]
32. Different anthracycline derivates for reducing cardiotoxicity in cancer patients.
van Dalen EC; Michiels EM; Caron HN; Kremer LC
Cochrane Database Syst Rev; 2006 Oct; (4):CD005006. PubMed ID: 17054231
[TBL] [Abstract][Full Text] [Related]
33. Comparison of epirubicin and doxorubicin cardiotoxicity induced by low doses: evolution of the diastolic and systolic parameters studied by radionuclide angiography.
Cottin Y; Touzery C; Dalloz F; Coudert B; Toubeau M; Riedinger A; Louis P; Wolf JE; Brunotte F
Clin Cardiol; 1998 Sep; 21(9):665-70. PubMed ID: 9755384
[TBL] [Abstract][Full Text] [Related]
34. Late characterisation of cardiac effects following anthracycline and trastuzumab treatment in breast cancer patients.
Kimball A; Patil S; Koczwara B; Raman KS; Perry R; Grover S; Selvanayagam J
Int J Cardiol; 2018 Jun; 261():159-161. PubMed ID: 29576422
[TBL] [Abstract][Full Text] [Related]
35. Speckle tracking echocardiography predicts early subclinical anthracycline cardiotoxicity in patients with breast cancer.
Tang Q; Jiang Y; Xu Y; Xia H
J Clin Ultrasound; 2017 May; 45(4):222-230. PubMed ID: 27910996
[TBL] [Abstract][Full Text] [Related]
36. Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors.
Jordan JH; Vasu S; Morgan TM; D'Agostino RB; Meléndez GC; Hamilton CA; Arai AE; Liu S; Liu CY; Lima JA; Bluemke DA; Burke GL; Hundley WG
Circ Cardiovasc Imaging; 2016 Aug; 9(8):. PubMed ID: 27502058
[TBL] [Abstract][Full Text] [Related]
37. Imaging doxorubicin and polymer-drug conjugates of doxorubicin-induced cardiotoxicity with bispecific anti-myosin-anti-DTPA antibody and Tc-99m-labeled polymers.
Panwar R; Bhattarai P; Patil V; Gada K; Majewski S; Khaw BA
J Nucl Cardiol; 2019 Aug; 26(4):1327-1344. PubMed ID: 29392624
[TBL] [Abstract][Full Text] [Related]
38. Myocardial Elasticity Imaging Correlates with Histopathology in a Model of Anthracycline-Induced Cardiotoxicity.
Miller CE; Jordan JH; Thomas A; Friday SR; Meléndez GC; Weis JA
bioRxiv; 2023 Oct; ():. PubMed ID: 37904976
[TBL] [Abstract][Full Text] [Related]
39. Impact of exercise training on cardiotoxicity and cardiac health outcomes in women with breast cancer anthracycline chemotherapy: a study protocol for a randomized controlled trial.
Antunes P; Esteves D; Nunes C; Sampaio F; Ascensão A; Vilela E; Teixeira M; Amarelo AL; Joaquim A
Trials; 2019 Jul; 20(1):433. PubMed ID: 31307527
[TBL] [Abstract][Full Text] [Related]
40. [
Oudot A; Courteau A; Guillemin M; Vrigneaud JM; Walker PM; Brunotte F; Cochet A; Collin B
EJNMMI Res; 2021 Sep; 11(1):92. PubMed ID: 34542689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
